Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Infographic
Jan 9, 2020
| Erica Klinger
Give IPR the Green Light
Press Release
Jan 8, 2020
| Rachel Schwartz
AAM Statement on "The Unintended Economics of the BLOCKING Act" Report
Press Release
Jan 7, 2020
| Rachel Schwartz
Katherine Michelle Raab Joins AAM as Vice President, Federal Government Affairs
Report
Jan 1, 2020
| Erica Klinger
The Unintended Economics of the BLOCKING Act
Video
Dec 20, 2019
| Erica Klinger
The CREATES Act Passed! — #PassedCREATES
Press Release
Dec 19, 2019
| Rachel Schwartz
USMCA Sets a New Standard for Lowering Drug Prices and Expanding Access to Medicines
Blog
Dec 18, 2019
| Kristin Murphy
Women-Powered Health Policy: 500 and Counting
Press Release
Dec 17, 2019
| Rachel Schwartz
AAM Applauds House Passage of the CREATES Act
Video
Dec 17, 2019
| Erica Klinger
USMCA Trade Agreement: A Victory for America’s Patients — #FixedUSMCA
Press Release
Dec 13, 2019
| Rachel Schwartz
AAM Statement on HR 3
Fact Sheet
Dec 12, 2019
| Chip Davis
Letter from AAM: Mr. President, Block the BLOCKING Act!
Fact Sheet
Dec 11, 2019
| Erica Klinger
Generic Drug Savings in the U.S.
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action